Sign Up to like & get
recommendations!
0
Published in 2018 at "Advances in Therapy"
DOI: 10.1007/s12325-018-0795-9
Abstract: Inflammatory bowel disease (IBD) is a chronic heterogeneous group of diseases that has undergone major advances in the understanding of its etiology and pathogenesis in recent years. The development of biologics had resulted in better…
read more here.
Keywords:
therapies inflammatory;
bowel disease;
inflammatory bowel;
disease ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Digestion"
DOI: 10.1159/000502816
Abstract: Extraintestinal manifestations (EIM) have become an important source of morbidity and disability as well as an identified risk factor for an unfavorably course of disease in inflammatory bowel diseases (IBD). Therefore, efforts have been put…
read more here.
Keywords:
extraintestinal manifestations;
therapies inflammatory;
bowel disease;
disease patients ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Current pharmaceutical design"
DOI: 10.2174/138161282527191007151037
Abstract: Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia; King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; Enzymoics, Hebersham, NSW, Australia; Novel Global Community Educational Foundation,…
read more here.
Keywords:
therapies inflammatory;
mediated pathogenesis;
autoimmune diseases;
pathogenesis therapies ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1129906
Abstract: Cumulative evidence along several lines indicates that B cells play an important role in the pathological course of multiple sclerosis (MS), neuromyelitisoptica spectrum disorders (NMOSD) and related CNS diseases. This has prompted extensive research in…
read more here.
Keywords:
cell;
inflammatory autoimmune;
therapies inflammatory;
targeted therapies ... See more keywords